Ribosomopathies and cancer: pharmacological implications.
Temaj G, Saha S, Dragusha S, Ejupi V, Buttari B, Profumo E, Beqa L, Saso L.
Temaj G, et al. Among authors: dragusha s.
Expert Rev Clin Pharmacol. 2022 Jun;15(6):729-746. doi: 10.1080/17512433.2022.2098110. Epub 2022 Jul 15.
Expert Rev Clin Pharmacol. 2022.
PMID: 35787725